Sectors
PRAX
Praxis Precision Medicines, Inc.
309.80
1 x 312.22
1 x 313.23
bid
ask
-
8.07
2.54%
10:01 AM
timesize
| Ytd | 5.11% | |
| 1y | 459.10% |
309.38
day range
316.00
37.19
52 week range
366.52
| Open | 311.52 | Prev Close | 317.87 | Low | 309.38 | High | 316.00 | Mkt Cap | 6.72B |
| Vol | 21.94K | Avg Vol | 489.85K | EPS | -13.37 | P/E | -23.77 | Forward P/E | -35.51 |
| Beta | 2.74 | Short Ratio | 7.27 | Inst. Own | 116.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 311.52 | 200-d Avg | 274.17 | 1yr Est | 610.05 |
| Income Statement | |||
| Operating Expenses | 105.86M | ||
| Research and Development Expense | 77.99M | ||
| Selling, General and Administrative Expense | 27.87M | ||
| Operating Income | -105.86M | ||
| Net Income | -92.56M | ||
| Net Income Common Stock | -92.56M | ||
| Net Income Common Stock (USD) | -92.56M | ||
| Consolidated Income | -92.56M | ||
| Earnings per Basic Share | -3.20 | ||
| Earnings per Basic Share (USD) | -3.20 | ||
| Earnings per Diluted Share | -3.20 | ||
| Earning Before Interest & Taxes (EBIT) | -92.56M | ||
| Earning Before Interest & Taxes (USD) | -92.56M | ||
| Weighted Average Shares | 28.88M | ||
| Weighted Average Shares Diluted | 28.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 536.33M | ||
| Cash and Equivalents (USD) | 536.33M | ||
| Investments | 911.47M | ||
| Investments Current | 250.53M | ||
| Investments Non-Current | 660.94M | ||
| Current Assets | 797.77M | ||
| Property, Plant & Equipment Net | 1.49M | ||
| Total Assets | 1.46B | ||
| Debt Current | 1.44M | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 50.24M | ||
| Total Liabilities | 50.24M | ||
| Accumulated Retained Earnings (Deficit) | -1.23B | ||
| Accumulated Other Comprehensive Income | -1.59M | ||
| Shareholders Equity | 1.41B | ||
| Shareholders Equity (USD) | 1.41B | ||
| Assets Non-Current | 662.43M | ||
| Total Debt (USD) | 1.44M | ||
| Trade and Non-Trade Payables | 31.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 236.00K | ||
| Net Cash Flow from Financing | 609.43M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 179.00M | ||
| Capital Expenditure | -62.00K | ||
| Issuance (Purchase) of Equity Shares | 622.35M | ||
| Net Cash Flow from Investing | -344.27M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -344.21M | ||
| Net Cash Flow from Operations | -86.15M | ||
| Share Based Compensation | 17.11M | ||